TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $115 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.4%

Neg 0% Neu 86.4% Pos 0%

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $115 price target.

Comments

No comments yet. Be the first!